Abstract:Clostridium difficile (C. difficile) toxin B (TcdB) is as an inflammatory enterotoxin that accounts for manifestations of widespread healthcare-associated C. difficile infection, including colonic inflammation. The present work explored the molecular mechanism by which TcdB activates innate immunity and stimulates pro-inflammatory cytokine release. Fetal human colon epithelial cells (FHCs) were treated with recombinant TcdB protein. Cell growth inhibition and apoptosis were measured with Cell Counting Kit-8 and Annexin V-fluorescein isothiocyanate Apoptosis Detection Kit, respectively. Flow cytometry analysis was also performed. Inflammatory cytokine induction was determined with enzykeme-linked immunosorbent assay analyses. Protein expression was assessed by western blot analysis. Gene overexpression and knockdown were performed with lentiviral transduction. Real-time quantitative polymerase chain reaction was used to examine gene expression. Dual-luciferase reporter assays and chromatin immunoprecipitation were implemented to explore transcriptional regulation. Mouse colon tissues were analyzed with hematoxylin and eosin staining. The results show that TcdB-induced cell growth and apoptosis and enhanced expression of interleukin-6 and tumor necrosis factor alpha in FHCs. We identified protein phosphatase magnesium-dependent 1B (PPM1B) as the key mediator promoting the phosphorylation of nuclear factor-κB p65, which accounted for the increase in pro-inflammatory cytokines. The findings demonstrate that PPM1B expression is directly regulated by the AKT/FOXO3 signaling pathway in FHCs. We confirmed the molecular mechanism with in vivo studies using a mouse model infected with C. difficile and treated with a phosphoinositide 3-kinase/AKT signaling inhibitor. In conclusion, TcdB induces inflammation in human colon epithelial cells by regulating the AKT/FOXO3/PPM1B pathway.

Frizzled Proteins Are Colonic Epithelial Receptors for C. Difficile Toxin B.

Structural Basis for Recognition of Frizzled Proteins by Clostridium Difficile Toxin B.

Sulfated glycosaminoglycans and low-density lipoprotein receptor contribute to Clostridium difficile toxin A entry into cells

Structural Insight into Wnt Signaling Inhibition by Clostridium Difficile Toxin B

Structural Dynamics of Receptor Recognition and Ph-Induced Dissociation of Full-Length Clostridioides Difficile Toxin B.

Identification of an Epithelial Cell Receptor Responsible for Clostridium Difficile TcdB-induced Cytotoxicity

Identification of TFPI As a Receptor Reveals Recombination-Driven Receptor Switching in Clostridioides Difficile Toxin B Variants

TFPI is a colonic crypt receptor for TcdB from hypervirulent clade 2 C. difficile

Receptor Binding Domains of TcdB from <i>Clostridioides difficile</i> for Chondroitin Sulfate Proteoglycan-4 and Frizzled Proteins Are Functionally Independent and Additive

Nectin-3 and shed forms of CSPG4 can serve as epithelial cell receptors for Clostridioides difficile TcdB

Chondroitin Sulfate Proteoglycan 4 Functions As the Cellular Receptor for Clostridium Difficile Toxin B.

Inhibition of EGFR/ErbB does not protect against C. difficile toxin B

Functional analyses of epidemic Clostridioides difficile toxin B variants reveal their divergence in utilizing receptors and inducing pathology

Critical Roles of Clostridium Difficile Toxin B Enzymatic Activities in Pathogenesis

Low-density Lipoprotein Receptor-Related Protein 1 is a CROPs-associated Receptor for Clostridioides Infection Toxin B.

Clostridium Difficile Toxin B-induced Colonic Inflammation is Mediated by the FOXO3/PPM1B Pathway in Fetal Human Colon Epithelial Cells.

Identification of an Essential Region for Translocation of Clostridium difficile Toxin B

Structural and functional insight into the interaction of Clostridioides difficile toxin B and FZD7

Clostridium difficile toxin B intoxicated mouse colonic epithelial CT26 cells stimulate the activation of dendritic cells.

Novel Cysteine Desulfidase CdsB Involved in Releasing Cysteine Repression of Toxin Synthesis in Clostridium Difficile

C. difficile intoxicates neurons and pericytes to drive neurogenic inflammation